Anti-DR3 Reference Antibody (Novo Nordisk patent anti-DR3), Monoclonal

Produktübersicht

• Artikelname: Anti-DR3 Reference Antibody (Novo Nordisk patent anti-DR3), Monoclonal
• Artikelnummer: SYB-CHB826
• Hersteller Artikelnummer: CHB826
• Alternativnummer: SYB-CHB826-100UG, SYB-CHB826-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics

Produktbeschreibung

Anti-DR3 Reference Antibody (Novo Nordisk patent anti-DR3)(CHB826) is expressed from CHO. The heavy chain type is IgG4SP-Opti, and the light chain type is kappa. It has a predicted MW of 145.5 kDa.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1mg/ml
• UniProt: Q93038
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: DR3